403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
Sernova Biotherapeutics
(MENAFN- Baystreet) 09:57 AM EST - Sernova Biotherapeutics : Announced the formation of its Clinical Advisory Board. The board will consist of five members and will be chaired by Dr. Robert Gabbay. This globally respected group of experts will provide critical guidance as the company advances clinical development of its Cell Pouch Bio-hybrid Organ with islet cells in patients with T1D. Sernova Biotherapeutics
shares T are trading down $0.01 at $0.22.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research
- Invictus Growth Partners Closes Oversubscribed Fund II With Funds Totaling $574 Million
- Bitmex Launches June Jumpstart Trading Competition With A 3 BTC Prize Pool
- From Private Equity To Public: Trace ASI's AI For Crypto Hits 87% Success Rate
- B2BROKER Launches First-Ever Turnkey Liquidity Provider Solution
- Nodit Launches Blockchain MCP To Bring Blockchain Context To Gpts And AI Tools
- AB Launches On Binance
More Story
Comments
No comment